India Aims to Reduce Dependence on China for Pharma Market
India Aims to Reduce Dependence on China for Pharma Market
NEW DELHI--March 20, 2024--Researched by Industrial Info Resources (Sugar Land, Texas)--India's Pharmaceutical & Biotech Industry, which supplies nearly half of the world's vaccines, is the third-largest producer by volume and 14th largest by value globally. It is projected to reach US$130 billion in value by 2030. However, it depends heavily on Chinese imports for active pharmaceutical ingredients (APIs) and other basic chemicals. The API is the part of the drug responsible for producing the intended medicinal effect.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- U.S. Supplement Production Brings Millions in Spending
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips